Trial intelligence / Profile preview

CPP-ACP Varnish vs TCP Varnish for Postorthodontic White Spot Lesions

NCT03217084Phase 4Unknown

Sponsor
Cairo University
Start
Dec 2017
Primary completion
Sep 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of casein phosphopeptide-amorphous calcium phosphate, tricalcium phosphate in White spot lesion (WSL), sponsored by Cairo University. Status: unknown.

02

Drugs

casein phosphopeptide-amorphous calcium phosphatetricalcium phosphate
03

Conditions

White spot lesion (WSL)

Beyond the preview

Go deeper on NCT03217084.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03217084.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call